$IMG
Stock $img

$img Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224033132 Filed on August 19, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue		$366.9K
YoY Change		-43.43%
Cost Of Revenue		$513.1K
YoY Change		-13.97%
Gross Profit		-$146.2K
YoY Change		-380.35%
Gross Profit Margin		-39.85%
Selling, General & Admin		$54.24K
YoY Change		200.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$33.92K
YoY Change		-50.62%
% of Gross Profit
Operating Expenses		$1.335M
YoY Change		-35.42%
Operating Profit		-$1.482M
YoY Change		-26.5%
Interest Expense		-$1.780K
YoY Change		-214.84%
% of Operating Profit
Other Income/Expense, Net		$290.9K
YoY Change		-2713.93%
Pretax Income		-$1.192M
YoY Change		-41.12%
Income Tax
% Of Pretax Income
Net Earnings		-$1.440M
YoY Change		-28.89%
Net Earnings / Revenue		-392.54%
Basic Earnings Per Share		-$0.92
Diluted Earnings Per Share		-$0.92
COMMON SHARES
Basic Shares Outstanding	5.005M shares	1.298M shares
Diluted Shares Outstanding		1.561M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$374.5K
YoY Change		-88.59%
Cash & Equivalents		$374.5K
Short-Term Investments
Other Short-Term Assets		$240.9K
YoY Change		-14.96%
Inventory		$937.2K
Prepaid Expenses
Receivables		$371.8K
Other Receivables		$0.00
Total Short-Term Assets		$1.924M
YoY Change		-61.97%
LONG-TERM ASSETS
Property, Plant & Equipment		$375.5K
YoY Change		4.3%
Goodwill
YoY Change
Intangibles		$87.50K
YoY Change		-25.53%
Long-Term Investments		$158.5K
YoY Change		-3.54%
Other Assets		$2.353K
YoY Change		-97.19%
Total Long-Term Assets		$824.1K
YoY Change		-31.12%
TOTAL ASSETS
Total Short-Term Assets		$1.924M
Total Long-Term Assets		$824.1K
Total Assets		$2.748M
YoY Change		-56.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$2.378M
YoY Change		106.4%
Accrued Expenses		$100.7K
YoY Change		-66.15%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$222.0K
YoY Change		527.59%
Total Short-Term Liabilities		$2.726M
YoY Change		45.08%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change		-100.0%
Other Long-Term Liabilities		$215.9K
YoY Change		357.23%
Total Long-Term Liabilities		$215.9K
YoY Change		0.79%
TOTAL LIABILITIES
Total Short-Term Liabilities		$2.726M
Total Long-Term Liabilities		$215.9K
Total Liabilities		$2.942M
YoY Change		40.55%
SHAREHOLDERS EQUITY
Retained Earnings		-$78.61M
YoY Change		11.04%
Common Stock		$78.27M
YoY Change		4.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$193.6K
YoY Change
Total Liabilities & Shareholders Equity		$2.748M
YoY Change		-56.07%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income		-$1.440M
YoY Change		-28.89%
Depreciation, Depletion And Amortization		$33.92K
YoY Change		-50.62%
Cash From Operating Activities		-$961.7K
YoY Change		-30.06%
INVESTING ACTIVITIES
Capital Expenditures		$4.100K
YoY Change		-77.68%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$4.100K
YoY Change		-77.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		1.747M
YoY Change		-28736.89%
NET CHANGE
Cash From Operating Activities		-961.7K
Cash From Investing Activities		-4.100K
Cash From Financing Activities		1.747M
Net Change In Cash		781.0K
YoY Change		-155.81%
FREE CASH FLOW
Cash From Operating Activities		-$961.7K
Capital Expenditures		$4.100K
Free Cash Flow		-$965.8K
YoY Change		-30.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024Q2	us-gaap	Cash Cash	374458	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	371845	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	937166	usd
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2387434	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2387434	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39338
	dei	Entity Registrant Name EntityRegistrantName	NUZEE, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3849791
	dei	Entity Address Address Line1 EntityAddressAddressLine1	2865 Scott St. Suite 107
	dei	Entity Address City Or Town EntityAddressCityOrTown	Vista
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92081
	dei	Local Phone Number LocalPhoneNumber	295-2408
	dei	Security12b Title Security12bTitle	Common Stock, $0.00001 par value
	dei	Trading Symbol TradingSymbol	NUZE
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5005170	shares
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	499582	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	772825	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
	dei	Entity Central Index Key EntityCentralIndexKey	0001527613
CY2024Q2	NUZE	Assets Held For Disposition Current AssetsHeldForDispositionCurrent		usd
CY2024Q2	NUZE	Assets Held For Disposition Non Current AssetsHeldForDispositionNonCurrent		usd
CY2024Q2	NUZE	Liabilities Held For Disposition Current LiabilitiesHeldForDispositionCurrent		usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q2	NUZE	Liabilities Held For Disposition Noncurrent LiabilitiesHeldForDispositionNoncurrent		usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2023Q2	NUZE	Discontinued Operation Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
	NUZE	Discontinued Operation Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationLossOnDisposalOfDiscontinuedOperationNetOfTax		usd
CY2022Q4	NUZE	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits		usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities		usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
	NUZE	Proceeds From Sales Of Future Receipts ProceedsFromSalesOfFutureReceipts		usd
	NUZE	Repayment Of Equipment Finance RepaymentOfEquipmentFinance		usd
	NUZE	Proceeds From Equipment Finance ProceedsFromEquipmentFinance		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations		usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations		usd
	NUZE	Interest Paid Net Discontinued InterestPaidNetDiscontinued		usd
	NUZE	Interest Paid Net Discontinued InterestPaidNetDiscontinued		usd
	NUZE	Income Taxes Paid Net Discontinued IncomeTaxesPaidNetDiscontinued		usd
	NUZE	Income Taxes Paid Net Discontinued IncomeTaxesPaidNetDiscontinued		usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts		usd
	NUZE	Rights Of Use Assets And Liabilities Added During Period RightsOfUseAssetsAndLiabilitiesAddedDuringPeriod		usd
CY2023Q2	NUZE	Disposal Group Including Discontinued Loss From Disposition Of Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDispositionOfDiscontinuedOperations		usd
	NUZE	Disposal Group Including Discontinued Loss From Disposition Of Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDispositionOfDiscontinuedOperations		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount		usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2024Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023Q3	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q2	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsAggregateIntrinsicValueOutstanding		usd
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Non Options Exercisable Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsNonOptionsExercisableAggregateIntrinsicValueNonvested		usd
	dei	City Area Code CityAreaCode	(760)
CY2023Q3	us-gaap	Cash Cash	982869	usd
CY2023Q3	NUZE	Assets Held For Disposition Current AssetsHeldForDispositionCurrent	706925	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	240906	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	414048	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	1924375	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	3376249	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375498	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	184763	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	200295	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	403258	usd
CY2024Q2	us-gaap	Investments Investments	158470	usd
CY2023Q3	us-gaap	Investments Investments	162259	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	87500	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	110000	usd
CY2023Q3	NUZE	Assets Held For Disposition Non Current AssetsHeldForDispositionNonCurrent	197409	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2353	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7060	usd
CY2024Q2	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	448618	usd
CY2023Q3	us-gaap	Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment	879986	usd
CY2024Q2	us-gaap	Assets Assets	2748491	usd
CY2023Q3	us-gaap	Assets Assets	4440998	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2378370	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1814035	usd
CY2024Q2	us-gaap	Loans Payable Current LoansPayableCurrent	221154	usd
CY2023Q3	us-gaap	Loans Payable Current LoansPayableCurrent	4753	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	100712	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	216128	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	824	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	26048	usd
CY2024Q2	us-gaap	Deferred Income Current DeferredIncomeCurrent	25127	usd
CY2023Q3	us-gaap	Deferred Income Current DeferredIncomeCurrent	379795	usd
CY2023Q3	NUZE	Liabilities Held For Disposition Current LiabilitiesHeldForDispositionCurrent	115644	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2726187	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2556403	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162301	usd
CY2023Q3	NUZE	Liabilities Held For Disposition Noncurrent LiabilitiesHeldForDispositionNoncurrent	47937	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	215917	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	215917	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	210238	usd
CY2024Q2	us-gaap	Liabilities Liabilities	2942104	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2766641	usd
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	748644	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	748644	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	24	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	8	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	78266339	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	74925843	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-78614726	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73371987	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	154750	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	120493	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-193613	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1674357	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2748491	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4440998	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	366888	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	268023	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1641955	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1205123	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	513101	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	262474	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1820140	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1237315	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-146213	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	5549	usd
	us-gaap	Gross Profit GrossProfit	-178185	usd
	us-gaap	Gross Profit GrossProfit	-32192	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	1335371	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	1882269	usd
	us-gaap	Operating Expenses OperatingExpenses	4748076	usd
	us-gaap	Operating Expenses OperatingExpenses	5794126	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1481584	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1876720	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4926261	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5826318	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1666	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1853	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3789	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5350	usd
CY2024Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	335838	usd
CY2023Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	49338	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	412580	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	139601	usd
CY2024Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	44913	usd
CY2023Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	60353	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	145140	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	181667	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-109	usd
CY2023Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	3298	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-1277	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	15573	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1192434	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1886290	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4663887	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-5858161	usd
CY2024Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-98086	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-139047	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-429175	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-318255	usd
CY2024Q2	NUZE	Discontinued Operation Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationLossOnDisposalOfDiscontinuedOperationNetOfTax	-149677	usd
	NUZE	Discontinued Operation Loss On Disposal Of Discontinued Operation Net Of Tax DiscontinuedOperationLossOnDisposalOfDiscontinuedOperationNetOfTax	-149677	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1440197	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2025337	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5242739	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6176416	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.76
CY2024Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.76
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.45
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.45
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-3.48
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-3.48
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-8.18
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-8.18
CY2024Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.06
CY2024Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.06
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.18
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.18
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.32
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.32
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.44
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.44
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.92
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.92
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.63
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.91
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.62
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1561410	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1561410	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	770063	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	770063	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1341059	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1341059	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	716388	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	716388	shares
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1440197	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2025337	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-16309	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-19331	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-16309	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19331	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1456506	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2044668	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5242739	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6176416	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	34257	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	53287	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	34257	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	53287	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5208482	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6123129	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1674357	usd
CY2023Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1277118	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	11505	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	129662	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	42408	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-2148611	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	986439	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	54443	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	29994	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8158	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-1653931	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-574897	usd
CY2024Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1819999	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	17791	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-16309	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1440197	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-193613	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9742799	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	197108	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	62839	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	115583	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-2183206	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7935123	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	57120	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	25000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	-114482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	51940	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42965	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1967873	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5943863	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	78750	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	15000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	107754	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	61996	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19331	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19331	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2025337	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4162695	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5242739	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6176416	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-429175	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-318255	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	142107	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	175995	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	308788	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	171718	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	83739	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	367155	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	135870	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24049	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	24049	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-41108	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3789	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5350	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-103688	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-99428	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	164341	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	218394	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-173142	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-218271	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4707	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7061	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	564335	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	390793	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-354668	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	28934	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-383542	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-195366	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	37229	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4270542	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4606189	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	310342	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31813	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-310342	usd
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-31813	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	429933	usd
	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	5932	usd
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	398754	usd
	NUZE	Proceeds From Sales Of Future Receipts ProceedsFromSalesOfFutureReceipts	195001	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	25224	usd
	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	21729	usd
	NUZE	Repayment Of Equipment Finance RepaymentOfEquipmentFinance	31626	usd
	NUZE	Proceeds From Equipment Finance ProceedsFromEquipmentFinance	262893	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	320000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1277118	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	1659655	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3626638	usd
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-27661	usd
	NUZE	Net Income Loss From Discontinued Operations NetIncomeLossFromDiscontinuedOperations	429175	usd
	NUZE	Net Income Loss From Discontinued Operations NetIncomeLossFromDiscontinuedOperations	318255	usd
	NUZE	Depreciation Discontinued Operations DepreciationDiscontinuedOperations	3690	usd
	NUZE	Depreciation Discontinued Operations DepreciationDiscontinuedOperations	5337	usd
	NUZE	Discontinued Operations Changes In Operating Assets And Liabilities DiscontinuedOperationsChangesInOperatingAssetsAndLiabilities	-737063	usd
	NUZE	Discontinued Operations Changes In Operating Assets And Liabilities DiscontinuedOperationsChangesInOperatingAssetsAndLiabilities	403545	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	311578	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-716463	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34257	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53287	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-608411	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5328839	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	982869	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8262319	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	374458	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2933480	usd
	us-gaap	Interest Paid Net InterestPaidNet	1416	usd
	us-gaap	Interest Paid Net InterestPaidNet	3760	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3048	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8090	usd
	NUZE	Forgiveness Of Stock Issuance Costs ForgivenessOfStockIssuanceCosts	40000	usd
	NUZE	Rights Of Use Assets And Liabilities Added During Period RightsOfUseAssetsAndLiabilitiesAddedDuringPeriod	105825	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	157440	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	380584	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	842121	usd
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	1360998	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	149875	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	333980	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	773534	usd
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	1164491	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	7565	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	46604	usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	68587	usd
	us-gaap	Disposal Group Including Discontinued Operation Gross Profit Loss DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss	196507	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	106480	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	185646	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	476532	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	533918	usd
CY2024Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-98915	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-139042	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-407945	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-337411	usd
CY2024Q2	NUZE	Disposal Group Including Discontinued Other Income And Expense DisposalGroupIncludingDiscontinuedOtherIncomeAndExpense	829	usd
CY2023Q2	NUZE	Disposal Group Including Discontinued Other Income And Expense DisposalGroupIncludingDiscontinuedOtherIncomeAndExpense	-5	usd
	NUZE	Disposal Group Including Discontinued Other Income And Expense DisposalGroupIncludingDiscontinuedOtherIncomeAndExpense	-21230	usd
	NUZE	Disposal Group Including Discontinued Other Income And Expense DisposalGroupIncludingDiscontinuedOtherIncomeAndExpense	19156	usd
CY2024Q2	NUZE	Disposal Group Including Discontinued Loss From Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDiscontinuedOperations	-98086	usd
CY2023Q2	NUZE	Disposal Group Including Discontinued Loss From Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDiscontinuedOperations	-139047	usd
	NUZE	Disposal Group Including Discontinued Loss From Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDiscontinuedOperations	-429175	usd
	NUZE	Disposal Group Including Discontinued Loss From Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDiscontinuedOperations	-318255	usd
CY2024Q2	NUZE	Disposal Group Including Discontinued Loss From Disposition Of Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDispositionOfDiscontinuedOperations	-149677	usd
	NUZE	Disposal Group Including Discontinued Loss From Disposition Of Discontinued Operations DisposalGroupIncludingDiscontinuedLossFromDispositionOfDiscontinuedOperations	-149677	usd
CY2024Q2	NUZE	Disposal Group Including Discontinued Net Loss DisposalGroupIncludingDiscontinuedNetLoss	-247763	usd
CY2023Q2	NUZE	Disposal Group Including Discontinued Net Loss DisposalGroupIncludingDiscontinuedNetLoss	-139047	usd
	NUZE	Disposal Group Including Discontinued Net Loss DisposalGroupIncludingDiscontinuedNetLoss	-578852	usd
	NUZE	Disposal Group Including Discontinued Net Loss DisposalGroupIncludingDiscontinuedNetLoss	-318255	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84F_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_ziCng5wW4MT6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="background-color: white"><i><span id="xdx_865_ztr3gp4a0Nc5">Reclassifications of Prior Year Amounts</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #212529"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="background-color: white">Certain prior year amounts have been reclassified for consistency with the current year presentation. The reclassifications had no effect on the reported results of operations or net assets of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	ratio from 1-for-10 to 1-for-50
CY2022Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-35
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	225225	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	253862	shares
CY2024Q2	us-gaap	Cash Cash	374458	usd
CY2024Q2	NUZE	Working Capital WorkingCapital	801812	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zOypduCHcFul" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span id="xdx_869_zwCeYV5WIMy">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In preparing these consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zIpsCKeSzabg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><i><span id="xdx_867_zbEBPrY44JDj">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company places its cash with high quality banking institutions. From time to time, the Company may or may not maintain cash balances at certain institutions in excess of the Federal Deposit Insurance Corporation limit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	82685	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	58636	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y9M
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	403258	usd
	NUZE	Addition For Right Of Use Of Assets AdditionForRightOfUseOfAssets	105825	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	308788	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	200295	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	378429	usd
	NUZE	Addition For Lease Liability AdditionForLeaseLiability	105825	usd
	NUZE	Operating Lease Lease Liability Amortization Expense OperatingLeaseLeaseLiabilityAmortizationExpense	383542	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	100712	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	100712	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	100712	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	100712	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	100712	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	100712	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	100712	usd
	us-gaap	Interest Expense InterestExpense	1416	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	140877	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1303	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	15297	usd
	us-gaap	Sublease Income SubleaseIncome	119275	usd
	us-gaap	Sublease Income SubleaseIncome	133443	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	34257	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	53287	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-3789	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-5350	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	240906	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	414048	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	240906	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	414048	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	937166	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	772825	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	920178	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	766916	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16988	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5909	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	937166	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	772825	usd
	us-gaap	Depreciation Depreciation	119607	usd
	us-gaap	Depreciation Depreciation	153495	usd
	NUZE	Property And Equipment Description PropertyAndEquipmentDescription	Expenditures associated with upgrades and enhancements that improve, add functionality, or otherwise extend the life of property and equipment that exceed $1,000 are capitalized.
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1456064	usd
CY2023Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	1145722	usd
CY2024Q2	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	57431	usd
CY2023Q3	us-gaap	Public Utilities Property Plant And Equipment Vehicles PublicUtilitiesPropertyPlantAndEquipmentVehicles	57431	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1137997	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1018390	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375498	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	184763	usd
	NUZE	Purchase Of Deposit Equipment PurchaseOfDepositEquipment	0	usd
CY2023	NUZE	Purchase Of Deposit Equipment PurchaseOfDepositEquipment	0	usd
CY2024Q1	NUZE	Accounts Receivable Face Discount Percentage AccountsReceivableFaceDiscountPercentage	0.03	pure
	NUZE	Outstanding Advances Amount OutstandingAdvancesAmount	73848	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	262893	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	87500	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	30000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22500	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	7500	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	30000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	30000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	20000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	87500	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	96458	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	150.39
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M2D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	30107	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	93.07
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Forfeited And Expired Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingForfeitedAndExpiredWeightedAverageRemainingContractualTerm2	P0Y
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	66351	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	175.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y3M7D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	59089	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	193.51
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y5M23D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	24029	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	80.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	16119	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	103.83
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	648	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	352.55
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	7262	shares
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	24.27
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	152398	shares
CY2023Q3	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	158.24
CY2023	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P2Y7M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	6476	shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Granted In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantedInPeriodWeightedAverageExercisePrice	2.64
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	158874	shares
CY2024Q2	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price1 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice1	151.90
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTerm	P2Y
	NUZE	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	158874	shares
	NUZE	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercisable In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisableInPeriodWeightedAverageExercisePrice	151.90
	NUZE	Sharebased Compensation Arrangement By Sharebased Payment Award Warrants Outstanding Weighted Average Remaining Contractual Term Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsOutstandingWeightedAverageRemainingContractualTermExercisable	P2Y
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p id="xdx_802_eus-gaap--LossContingencyDisclosures_zC01b3DlpoPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6. <span id="xdx_82B_zj5KWlfTXHU">CONTINGENCY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Steeped, Inc. Litigation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As previously disclosed, on January 27, 2023, Steeped, Inc. d/b/a Steeped Coffee (“Steeped”) filed a complaint against the Company in the Superior Court of California, Santa Cruz County (Case No. 23CV00234) (the “Steeped Litigation”). The Steeped Litigation relates to Steeped’s claim that the Company breached a 2021 settlement agreement that resolved Steeped’s 2019 trademark infringement case against the Company. The earlier case involved Steeped’s purported trademark protection for “steeped coffee” and related phrases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Steeped’s operative complaint in the pending Steeped Litigation alleges breach of contract, intentional interference with contractual relations, intentional interference with prospective economic advantage, and fraud in the inducement of contract. Plaintiff seeks a trial by jury and relief in the form of a permanent injunction for use of “Steep Coffee” or any confusingly similar variant of “STEEPED COFFEE”; the impoundment and destruction of allegedly violating packaging materials and/or finished goods; a final judgment for all profits derived from the Company’s allegedly unlawful conduct, actual damages, damages to the Plaintiff’s reputation and goodwill among its customers and partners; and reasonable attorneys’ fees and costs. NuZee answered Steeped’s complaint with a general denial and asserted twenty-five affirmative defenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 16, 2024, a mediation hearing was held. After the close of business, the mediator suggested a settlement amount of $<span id="xdx_900_eus-gaap--LossContingencyDamagesAwardedValue_c20240116__20240116_zxDtgmdMnX7a" title="Settlement amount">500,000</span> which both parties agreed to accept. On June 19, 2024 (the “Effective Date”), Steeped and the Company entered into a settlement agreement outlining the payment schedule for the $<span id="xdx_907_eus-gaap--LossContingencyDamagesAwardedValue_c20240619__20240619__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zROs7CdPkOG6" title="Settlement amount">500,000</span> according to the following schedule: $<span id="xdx_90E_eus-gaap--LossContingencyDamagesAwardedValue_c20240619__20240619__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--AwardTypeAxis__custom--WithinTwentyBusinessDaysMember_zLY5cZX9eLK1" title="Settlement amount">100,000</span> within 20 business days of the Effective Date, $<span id="xdx_90B_eus-gaap--LossContingencyDamagesAwardedValue_c20240619__20240619__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--AwardTypeAxis__custom--WithinFortyBusinessDaysMember_zG3hCDertAV8" title="Settlement amount">200,000</span> within 40 business days of the Effective Date and $<span id="xdx_902_eus-gaap--LossContingencyDamagesAwardedValue_c20240619__20240619__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember__us-gaap--AwardTypeAxis__custom--WithinEightyBusinessDaysMember_zmUfhP5rVKo9" title="Settlement amount">200,000</span> within 80 business days of the Effective Date. The settlement amount is accrued in the financial statements as of June 30, 2024 and is included in current liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Curtin Litigation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As previously disclosed, on January 6, 2023, a former employee of the Company, Rosaline Curtin (“Ms. Curtin”), filed a complaint against the Company and another former employee of the Company, Jose Ramirez (“Mr. Ramirez”), in the Superior Court of California, County of San Diego (Case No. 37-2023-00000841-CU-WT-NC) (the “Curtin Complaint”). The Curtin Complaint alleges that Ms. Curtin was subject to harassment by her supervisor, Mr. Ramirez, and gender discrimination throughout her employment, that she reported this discrimination and harassment to the Company, and that the Company retaliated against her and wrongfully terminated her for whistleblowing and failed to prevent discrimination, harassment, and retaliation. The Curtin Complaint seeks compensatory damages, including loss of past, present and future earnings, and benefits, as well as punitive damages, penalties, attorney’s fees and costs and interest. The Company has responded to the complaint on behalf of the Company and Mr. Ramirez and prevailed on December 22, 2023, prevailed on its motion to compel. Arbitration proceedings have been initiated, and the parties have agreed on an arbitrator. On May 24, 2024, a management conference was held in the arbitration and a hearing date was scheduled for January 13-17, 2025. Discovery is underway and the Company’s responses and objections to Curtin’s discovery demands are due on August 9, 2024. Curtin’s discovery responses and objections to the Company’s discovery demands are due on August 23, 2024. The Company believes the allegations set forth in the Curtin Complaint are without merit and intends to defend vigorously against the allegations. However, the Company is not able to predict the outcome, and there is no assurance that the Company will be successful in its defense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, we may be subject to other legal proceedings and claims in the ordinary course of business. The results of any future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 29, 2024, the Company received a letter from an investor alleging that the Company has breached a purported agreement by failing to satisfy certain alleged obligations. The investor has demanded fulfillment of the alleged obligations, undisclosed monetary damages, legal fees and interest. He has indicated he will seek Court intervention if the Company fails to adequately address his demands. The Company and its counsel are reviewing the matter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	500000	usd
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-033132-index-headers.html	Edgar Link	pending
0001493152-24-033132-index.html	Edgar Link	pending
0001493152-24-033132.txt	Edgar Link	pending
0001493152-24-033132-xbrl.zip	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuze-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
nuze-20240630_cal.xml	Edgar Link	unprocessable
nuze-20240630_def.xml	Edgar Link	unprocessable
nuze-20240630_lab.xml	Edgar Link	unprocessable
nuze-20240630_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IMG
Stock $img

2024 Q3 Form 10-Q Financial Statement

#000149315224033132 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG Stock $img

2024 Q3 Form 10-Q Financial Statement

#000149315224033132 Filed on August 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IMG
Stock $img